CytoMed Therapeutics Ltd
For the period ended Jun 30, 2026. Filed Sep 30, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 30, 2026 · Filed Sep 30, 2026
Use the contents to explore the available documents and sections.
GDTC$0.86-2.4%Stored close · as of Nov 6, 2026
Contents
EX-99.2 · Recent Developments
Recent Developments
On September 29, 2026, the Company entered into a shareholder loan agreement with a director for a principal amount of S$1 million, with a tenure of six months and an interest rate of 2.75% per annum.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.